Why platelet-rich plasma failed to promote bone healing in combination with a biphasic synthetic graft material in bone defects: a critical comment.

J Craniofac Surg

Department of Periodontology, Oral Research Center of CPLA, Hospital 411 of CPLA, Shanghai, People's Republic of China Department of Psychology, Aerospace Engineering Medical College, Fourth Military Medical University, Xi'an, People's Republic of China.

Published: July 2014

Download full-text PDF

Source
http://dx.doi.org/10.1097/SCS.0000000000000775DOI Listing

Publication Analysis

Top Keywords

platelet-rich plasma
4
plasma failed
4
failed promote
4
promote bone
4
bone healing
4
healing combination
4
combination biphasic
4
biphasic synthetic
4
synthetic graft
4
graft material
4

Similar Publications

Platelet-Rich Plasma for Treating COVID-19-Related Anosmia, Hyposmia, and Parosmia: A Controlled Longitudinal Study.

Otolaryngol Head Neck Surg

January 2025

Department of Otorhinolaryngology and Head and Neck Surgery, CHU Saint-Pierre, Brussels, Belgium.

Objective: To investigate the effectiveness of platelet-rich plasma (PRP) injection into the olfactory clefts of coronavirus disease 2019 (COVID-19) patients with persistent anosmia, hyposmia, and parosmia.

Study Design: Controlled study.

Setting: Multicenter study.

View Article and Find Full Text PDF

Platelet-rich plasma (PRP) is characterized by elevated concentrations of growth factors that facilitate bone repair. Nonetheless, the effective integration of PRP with bone implants and the sustained release of its active constituents pose significant challenges. In this study, thrombin is grafted onto the surface of polyetheretherketone (PEEK) via an N,N'-Disuccinimidyl Carbonate (DSC) linker and the retained enzymatic activity of thrombin enables the controlled activation of PRP self-assembly, resulting in the formation of a functional bio-gel layer.

View Article and Find Full Text PDF

The purpose of this in brief article was to determine the current role of intraarticular injections of hyaluronic acid (HA) and platelet-rich plasma (PRP) for the treatment of painful KOA. It has been reported that the average duration of effectiveness (pain relief) of one injection of extended-release HA is around one year. Kellgren-Lawrence grade (I-II versus III-IV), male gender, and older age are associated with a longer duration of effectiveness.

View Article and Find Full Text PDF

Background: Lateral epicondylitis is caused by overuse and manifests as pain, weakness, and difficulty with object manipulation. Platelet-rich plasma (PRP) and dextrose injections have shown promise in reducing pain and improving function.

Hypothesis: PRP is more effective for force precision control of the extensor carpi radialis brevis (ECRB) muscle than dextrose injection for patients with chronic lateral epicondylitis (CLE).

View Article and Find Full Text PDF

Background: The effectiveness of intra-articular platelet-rich plasma (IA-PRP) injections for managing pain in knee osteoarthritis (KOA) remains inconsistent. Therefore, this study aimed to systematically review randomized controlled trials (RCTs) assessing the efficacy of IA-PRP.

Methods: A total of 21 studies meeting the inclusion criteria were selected from various scientific databases, all of which compared PRP to either a placebo or an active comparator, such as corticosteroids (CS), in the treatment of KOA.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!